Jesse Bennett, a two-time prostate cancer survivor and Morgan State University health education graduate, uses his journey to inspire other men to take charge of their health by learning their PSA ...

Luton Someries Rotary Club has organised and subsidised a prostate cancer blood test ('PSA') clinic for men aged 40 years+ on ...

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 ...

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...

The importance of all health screenings is that they can detect issues early. Prostate cancer is one of the most common ...

Patients with D2T-PsA can be stratified into inflammatory and noninflammatory phenotypes, with the former linked to higher sonographic activity.

Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.

How do we know which patients truly need this difficult treatment and which patients can safely skip it? The answer has arrived, delivered at the American Society for Radiation Oncology (ASTRO) 2025 ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

This awareness gap could prevent earlier cancer detection, so one expert doctor is sharing crucial details you should know.

Lu]Lu-PSMA-617 radiopharmaceutical therapy has been approved for the treatment of men with metastatic castration-resistant ...